Worker safety legislation helps drive demand for safety needles, report indicates (10/28)
According to a recent report published by Global Industry Analysts, Inc., the market for disposable medical products such as syringes, disposable needles, and related products has expanded considerably due to increasing number of outpatient procedures. Increasing awareness of diseases such as HIV/AIDS, HCV, HBV, simplex virus, malaria, syphilis, typhus, and tuberculosis, in addition to new legislation dealing with worker safety, is expected to spur the demand for safety needles. Innovations in the disposable drug injection market, including single-use needleless injectors, and pre-filled injectors are poised to take a considerable market share from syringes. Increasing use of needleless I.V. systems and safety syringes is expected to deter the demand for conventional needles and syringes.
United States and Europe represent the leading markets in the global special purpose needles market, the report states, according to a recent press release. Although a mature market, United States special purpose needles presents growth prospects owing to the enhanced safety features. Strict federal laws and recommendations by the National Institute for Occupational Safety and Health (NIOSH) and Centers for Disease Control and Prevention (CDC) are adding impetus to the use of safety needles and needlefree injection systems. Hypodermic needles market in the United States is projected to reach U.S. $294.5 million by 2010. Rise in popularity of self-injection devices for patients with allergic asthma and migraine are also expected to boost the use of needles for self-administration of hypodermal medications.
Europe, France, Germany, and United Kingdom account for over 58% of annual special purpose needles market. In France, fastest growth is anticipated for intravenous needles, estimated at US$12.6 million for 2008.
Key players profiled in the report include Angiotech Pharmaceuticals Inc., Argon Medical Devices Inc., Becton, Dickinson and Company, B. Braun Medical Inc., Cardinal Health, Covidien Ltd., Ethicon Inc, Inrad Inc, Medline Industries Inc, Popper & Sons Inc., Smiths Medical, Specialized Health Products International Inc., TERUMO Corporation, and World Wide Medical Technologies.
The report titled “Special Purpose Needles: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., reviews major trends, issues, and competition in the market. The report enumerates recent developments, product introductions/innovations, mergers, acquisitions and other strategic industry activities. Segments analyzed in the report include Acupuncture Needles, Aspirating Needles, Biopsy Needles, Blood Collection Needles, Blunt Needles, Bone Marrow Needles, Cardiology Needles, Catheter Needles, Dental Needles, Dialysis Needles, Electrode Needles, Endoscopy Needles, Epidural Needles, Fistula Needles, Hypodermic Needles, Intra-arterial Needles, Intravenous Needles, Ophthalmic Needles, Pneumoperitoneum Needles, Radiology Needles, Spinal Needles, and Suture Needles. Analysis is presented for the period 2000-2015 for established and emerging markets including United States, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, Latin America, and Rest of World.
For more details of this research report, please visit http://www.strategyr.com/Special_Purpose_Needles_Market_Report.asp.
United States and Europe represent the leading markets in the global special purpose needles market, the report states, according to a recent press release. Although a mature market, United States special purpose needles presents growth prospects owing to the enhanced safety features. Strict federal laws and recommendations by the National Institute for Occupational Safety and Health (NIOSH) and Centers for Disease Control and Prevention (CDC) are adding impetus to the use of safety needles and needlefree injection systems. Hypodermic needles market in the United States is projected to reach U.S. $294.5 million by 2010. Rise in popularity of self-injection devices for patients with allergic asthma and migraine are also expected to boost the use of needles for self-administration of hypodermal medications.
Europe, France, Germany, and United Kingdom account for over 58% of annual special purpose needles market. In France, fastest growth is anticipated for intravenous needles, estimated at US$12.6 million for 2008.
Key players profiled in the report include Angiotech Pharmaceuticals Inc., Argon Medical Devices Inc., Becton, Dickinson and Company, B. Braun Medical Inc., Cardinal Health, Covidien Ltd., Ethicon Inc, Inrad Inc, Medline Industries Inc, Popper & Sons Inc., Smiths Medical, Specialized Health Products International Inc., TERUMO Corporation, and World Wide Medical Technologies.
The report titled “Special Purpose Needles: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., reviews major trends, issues, and competition in the market. The report enumerates recent developments, product introductions/innovations, mergers, acquisitions and other strategic industry activities. Segments analyzed in the report include Acupuncture Needles, Aspirating Needles, Biopsy Needles, Blood Collection Needles, Blunt Needles, Bone Marrow Needles, Cardiology Needles, Catheter Needles, Dental Needles, Dialysis Needles, Electrode Needles, Endoscopy Needles, Epidural Needles, Fistula Needles, Hypodermic Needles, Intra-arterial Needles, Intravenous Needles, Ophthalmic Needles, Pneumoperitoneum Needles, Radiology Needles, Spinal Needles, and Suture Needles. Analysis is presented for the period 2000-2015 for established and emerging markets including United States, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, Latin America, and Rest of World.
For more details of this research report, please visit http://www.strategyr.com/Special_Purpose_Needles_Market_Report.asp.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
